Pathology; GS4+4, 152 gr, Neg Margins ECE+ SVI- LN- Vasc-
My post RP PSA at 6 months = 0.224 and 9 months 0.29
PSADT is 8.7 months
I was ECE for 2 years or more before surgery.
With a GS4+4 I think I am systemic and that SRT is not a viable option
HT can weaken but does not kill all PCa cells
Otherwise HT could provide a cure for systemic disease
SRT can only kill in the Prostate bed and surroundings
One strategic camp says "Hit early, Hit hard"
But SRT + HT will not cure if the PCa is systemic
Taxotere is used to kill PCa cells in the later stages of disease
when HT fails and the PSA levels are high and tumors are large
So my idea
Why not use Taxotere to kill and provide a likely cure
for systemic disease in the EARLY stages when PSA levels
are low and tumors are tiny ?
Is there some reason this is not possible or that no
doctor will go along with it ?
Why has this not been offered as a standard option
for early high risk disease ?
I am willing to walk thru hell if it will give me a cure.
2000 1st PSA 12
Antibiotics then biopsy
Size is 4x, no PCa
Live with symptoms slowly getting worse
2007 1st AUR, ER visit PSA 14
2011 April 2 AUR, ER visits in one week
2011 April TURP Pathology No PCa
I thought PCa free Did not do DRE for 3 yrs, Sigh :-((
PSA was steady at 14; Free PSA to Bound PSA 37%
Both markers lied to me !
2014 Jan blood in urine DRE shows poss T4 PCa
Biopsy 7 cores right side all 50% PCa GS 3+4
2014 Feb Fly to NYC MSKCC
Bone scan neg MRI shows ECE
Biopsy slides reevaluation at 7 cores all 80% PCa
GS 4+3 upgraded, both lobes involved
Pre Op PSA 19
2014 3 April
Pathology; ECE+ LN- SV- Vasc - 152gms
Neg Margins, PNI + , half nerve taken one side
GS upgraded to 4+4 Grading pT3aN0MX
ED , Incont down to 1pad/day in 5 months
July 3mo Post OP PSA 0.224
August 4mo Post OP PSA 0.247
October 6mo Post OP PSA 0.29
PSADT 8.7 mo w MSKCC Nomogram
Post Edited (pablocito) : 12/3/2014 7:16:36 PM (GMT-7)